BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Policy

  Pfizer Inc. Strives to Prevent CEO From Testifying in Chantix Trial

  October 12, 2012

   · 

  1 min read
• Policy

  Coaxia Inc. Wins FDA Panel Date for Cerebral Ischemia Device

  October 12, 2012

   · 

  1 min read
• Drug Development

  Lexicon Pharmaceuticals, Inc. Rises With Advance of Key Drug

  October 12, 2012

   · 

  7 min read
• Business

  Pfizer Inc. Taps Execs for Animal Health Spin Off

  October 12, 2012

   · 

  1 min read
• Drug Development

  Novartis AG’s Gilenya Cuts Early Relapse, Brain Loss in MS Patients

  October 12, 2012

   · 

  9 min read
• FDA

  Alverix Technology Powers Rapid Detection of Respiratory Syncytial Virus

  October 12, 2012

   · 

  3 min read
• FDA

  Masimo Corporation Announces FDA Clearance and Launch of Pulse Oximetry Cable

  October 12, 2012

   · 

  6 min read
• Drug Development

  Biogen Idec, Inc. (Massachusetts) Release: New Data From Phase 3 Studies Provide Additional Evidence Supporting Treatment Effect for Oral BG-12 (Dimethyl Fumarate) in Multiple Sclerosis

  October 12, 2012

   · 

  1 min read
• Pharm Country

  Fibrocell Science, Inc. to Host Investor Conference Call to Discuss Business Update

  October 12, 2012

   · 

  1 min read
• Business

  Ceres, Inc.’ Richard Flavell to Become Chief Scientific Advisor

  October 12, 2012

   · 

  2 min read